Clinical Trials Logo

Kidney Diseases clinical trials

View clinical trials related to Kidney Diseases.

Filter by:

NCT ID: NCT03307707 Completed - Heart Failure Clinical Trials

New Heart Failure Biomarkers in Early Stage Chronic Kidney Disease-Mineral and Bone Disorder

CKD-MBD-HF
Start date: June 15, 2015
Phase: N/A
Study type: Observational

the objective of this study is to : -Determinate wether the circulating levels of iFGF23 and klotho can be a predictor biomarker of HF in patients with CKD-MBD.

NCT ID: NCT03306238 Recruiting - Kidney Diseases Clinical Trials

LAParoscopic Entry Technique in REnal Surgery

LAPRES
Start date: November 1, 2017
Phase: N/A
Study type: Interventional

This is a randomised controlled trial to evaluate safety and efficacy of two different port site entry techniques in laparoscopic renal surgery: open method (Hasson) and closed method (Veress). It will involve 300 adult patients undergoing elective laparoscopic renal surgery in Tallaght hospital under two Consultant urologists.

NCT ID: NCT03305211 Not yet recruiting - Kidney Disease Clinical Trials

Biological Collection in Nephrology for the Study of the Links Between Kidney Disease, Immunity System and Cardiovascular Complications

NéphroMIC²
Start date: December 15, 2017
Phase: N/A
Study type: Interventional

The NephoMIC project is a biological collection in patients of Nephrology, allowing the study of the links between kidney diseases, Immunity system and Cardiovascular complications. Its aim is to allow the development of a translational research on the theme of "Systemic Nephrology", which concerns both renal complications of autoimmune and inflammatory diseases, and systemic complications of patients with kidney disease, linked to both a state of immunosuppression and an increased risk of cardiovascular complications. It is based on the proximity between the Clinical investigation Center (CIC) of the hospital, where the samples are received, techniqued and preserved, and the Center of Nephrology and Renal Transplantation of the hospital. The collection includes blood samples (whole blood, serum, plasma, total blood RNA, PBMC cells), and urine samples (fresh urine). Participation in the collection is particularly recommended for patients who require a medical renal biopsy in the Nephrology Department. Other well-phenotyped patients (well-defined renal disease diagnosis) may also participate in NephroMIC.

NCT ID: NCT03303222 Not yet recruiting - Kidney Diseases Clinical Trials

Study to Develop a Breath Analyser to Detect Chronic Kidney Disease

Start date: February 10, 2021
Phase:
Study type: Observational

Measure trimethylamine oxide in the breath.

NCT ID: NCT03268850 Completed - Kidney Diseases Clinical Trials

Living Kidney Donor Lost Wages Trial

Start date: February 5, 2018
Phase: N/A
Study type: Interventional

This study aims to evaluate the effectiveness of offering reimbursement for living donor lost wages on the rate of live donor kidney transplantation.

NCT ID: NCT03246984 Completed - Kidney Diseases Clinical Trials

VALUE- Vascular Access Laminate eUropean Experience. A Post Market Surveillance Study to Assess the Safety and Effectiveness of VasQ

VALUE
Start date: September 7, 2017
Phase: N/A
Study type: Interventional

This is a prospective single arm study enrolling patients who are scheduled for creation of a new Brachiocephalic or Radiocephalic AV fistula. Up to 80 patients will be enrolled, 50 with upper arm AV fistula and 30 with forearm AV fistula. All patients will be implanted with the VasQ device, a subcutaneous arteriovenous conduit support for vascular access. The follow up period in this study will be for a duration of 12 months, with follow up visits scheduled at 1, 3, 6, 9, and 12 months.

NCT ID: NCT03220061 Completed - Kidney Diseases Clinical Trials

Effectiveness of Music Therapy on Blood Pressure and Anxiety Among Patients Undergoing Haemodialysis

Start date: December 12, 2016
Phase: N/A
Study type: Interventional

Effectiveness of music therapy on blood pressure and anxiety among patients undergoing haemodialysis

NCT ID: NCT03213158 Completed - Clinical trials for End Stage Renal Disease

Ixazomib for Desensitization

IXADES
Start date: September 15, 2017
Phase: Phase 2
Study type: Interventional

The purpose of this research study is to find out how well ixazomib (the study drug) works to desensitize highly sensitized kidney transplant recipients.

NCT ID: NCT03202914 Completed - Clinical trials for Dietary Modification

Metabolomics for Identifying Biomarkers of Dietary Intake and Kidney Disease Progression

MDRD
Start date: October 1988
Phase: N/A
Study type: Interventional

The present record represents a secondary data analysis of the Modification of Diet in Renal Disease (MDRD) Study. For this analysis, the MDRD study data and specimens were retrieved from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Central Repository. A global, untargeted, metabolomic profile was used to investigate biomarkers of dietary intake as well as biomarkers of kidney disease progression.

NCT ID: NCT03201939 Suspended - HIV/AIDS Clinical Trials

Optimal Management of HIV Infected Adults at Risk for Kidney Complications in Nigeria

Start date: July 1, 2024
Phase: Phase 2
Study type: Interventional

In this study, the Investigators plan to determine the optimal means to prevent or slow the progression of kidney disease among genetically at-risk northern Nigerian HIV-infected adults. Based on data from studies of diabetic kidney disease that used medications that block the renin angiotensin aldosterone system (RAAS), we plan to evaluate whether or not RAAS inhibition (using a widely available medication that blocks RAAS) in HIV-infected adults produces similarly promising results.